REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 15th, 2020 • Novus Therapeutics, Inc. • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is dated as of September 14, 2020, by and among Novus Therapeutics Inc., a Delaware corporation (the “Company”), and the several purchasers signatory hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
STOCK PURCHASE AGREEMENTStock Purchase Agreement • September 15th, 2020 • Novus Therapeutics, Inc. • Pharmaceutical preparations • New York
This Stock Purchase Agreement (this “Agreement”) is dated as of September 14, 2020, by and among Novus Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on Annex A hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
AGREEMENT AND PLAN OF MERGER by and among NOVUS THERAPEUTICS, INC., NAUTILUS MERGER SUB 1, INC., NAUTILUS MERGER SUB 2, LLC and ANELIXIS THERAPEUTICS, INC. Dated as of September 14, 2020Agreement and Plan of Merger • September 15th, 2020 • Novus Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of September 14, 2020, by and among NOVUS THERAPEUTICS, INC., a Delaware corporation (“Parent”), NAUTILUS MERGER SUB 1, INC., a Delaware corporation (“First Merger Sub”), NAUTILUS MERGER SUB 2, LLC, a Delaware limited liability company (“Second Merger Sub” and together with First Merger Sub, “Merger Subs”), and ANELIXIS THERAPEUTICS, INC., a Delaware corporation (the “Company”).
